Catalyst Pharmaceuticals, Inc. (CPRX)
 NASDAQ: CPRX · Real-Time Price · USD
 20.97
 -0.04 (-0.19%)
  At close: Oct 30, 2025, 4:00 PM EDT
20.85
 -0.12 (-0.57%)
  After-hours: Oct 30, 2025, 7:13 PM EDT
Catalyst Pharmaceuticals Market Cap
Catalyst Pharmaceuticals has a market cap or net worth of $2.57 billion as of October 30, 2025. Its market cap has increased by 4.77% in one year.
Market Cap 
 2.57B
Enterprise Value 
 1.92B
1-Year Change 
 4.77%
Ranking 
 Category 
 Stock Price 
$20.97
Market Cap Chart
Since December 15, 2006, Catalyst Pharmaceuticals's market cap has increased from $69.00M to $2.57B, an increase of 3,619.62%. That is a compound annual growth rate of 21.10%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 2.57B | 3.30% | 
| Dec 31, 2024 | 2.49B | 38.90% | 
| Dec 29, 2023 | 1.79B | -7.42% | 
| Dec 30, 2022 | 1.94B | 177.28% | 
| Dec 31, 2021 | 698.10M | 101.65% | 
| Dec 31, 2020 | 346.20M | -10.40% | 
| Dec 31, 2019 | 386.40M | 95.84% | 
| Dec 31, 2018 | 197.30M | -40.80% | 
| Dec 29, 2017 | 333.30M | 283.10% | 
| Dec 30, 2016 | 87.00M | -57.12% | 
| Dec 31, 2015 | 202.90M | -1.17% | 
| Dec 31, 2014 | 205.30M | 94.41% | 
| Dec 31, 2013 | 105.60M | 599.34% | 
| Dec 31, 2012 | 15.10M | -52.66% | 
| Dec 30, 2011 | 31.90M | 66.15% | 
| Dec 31, 2010 | 19.20M | 68.42% | 
| Dec 31, 2009 | 11.40M | -54.94% | 
| Dec 31, 2008 | 25.30M | -41.44% | 
| Dec 31, 2007 | 43.20M | -28.60% | 
| Dec 29, 2006 | 60.50M | -12.32% | 
| Dec 15, 2006 | 69.00M | - | 
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 735.95B | 
| Johnson & Johnson | 450.87B | 
| AbbVie | 403.13B | 
| UnitedHealth Group | 338.99B | 
| AstraZeneca | 259.35B | 
| Novartis AG | 250.89B | 
| Novo Nordisk | 235.38B | 
| Abbott Laboratories | 221.37B |